Infographic: Researchers Take Aim at Cancer Evolution
Infographic: Researchers Take Aim at Cancer Evolution
Strategies to trick, manipulate, and direct the evolution of tumors
Infographic: Researchers Take Aim at Cancer Evolution
Infographic: Researchers Take Aim at Cancer Evolution

Strategies to trick, manipulate, and direct the evolution of tumors

Strategies to trick, manipulate, and direct the evolution of tumors

cancer drugs
Biochemist Stanley Cohen Dies
Biochemist Stanley Cohen Dies
Catherine Offord | Feb 10, 2020
The Vanderbilt University professor was awarded a Nobel Prize for his discovery of epidermal growth factor.
Cancer Cells Increase DNA Mutations to Evade Treatment
Cancer Cells Increase DNA Mutations to Evade Treatment
Abby Olena | Nov 7, 2019
Colorectal tumor cells limit their DNA repair in response to a targeted therapy, giving them a greater chance to develop resistance to the drug.
Cancer Drugs in Development May Be Targeting Wrong Proteins
Cancer Drugs in Development May Be Targeting Wrong Proteins
Shawna Williams | Sep 12, 2019
A study of 11 drugs now in clinical trials suggests they do kill cancer cells—but through a different mechanism than indicated in previous research.
Genetically Personalized Fruit Flies Screen for Cancer Drugs
Genetically Personalized Fruit Flies Screen for Cancer Drugs
Ruth Williams | May 22, 2019
Fly avatars bearing multiple genetic changes akin to those of a cancer patient lead to a tailor-made treatment that has shrunk the patient’s tumors.
John Mendelsohn, Former MD Anderson Cancer Center President, Dies
John Mendelsohn, Former MD Anderson Cancer Center President, Dies
Ashley Yeager | Jan 10, 2019
The scientist and clinician helped develop a new form of cancer therapy, using a monoclonal antibody to treat head, neck, colorectal, and lung cancers.
Eli Lilly Will Buy Loxo Oncology for $8 BillionEli Lilly Will Buy Loxo Oncology for $8 Billion
Eli Lilly Will Buy Loxo Oncology for $8 Billion
Ashley Yeager | Jan 8, 2019
Loxo focuses on cancer treatments based on tumor genetics, which will contribute to Lilly’s push in the cancer drug space.
Bristol-Myers Squibb to Buy Celgene for $74 Billion
Bristol-Myers Squibb to Buy Celgene for $74 Billion
Catherine Offord | Jan 3, 2019
The deal between the two biopharmaceutical giants will boost the purchaser’s cancer drug portfolio.
Fecal Transplant Heals Colitis Caused by Immunotherapy
Fecal Transplant Heals Colitis Caused by Immunotherapy
Anna Azvolinsky | Nov 12, 2018
A case study of two patients with advanced cancer shows it might be possible to avoid a common and severe side effect of immunotherapy treatment.
Infographic: Cancer Drug Pairings
Infographic: Cancer Drug Pairings
Anna Azvolinsky | Mar 31, 2018
Researchers use several different strategies to deliver a one-two punch.